Korean Circ J.  2022 Jan;52(1):84-86. 10.4070/kcj.2021.0382.

Post-pericardiocentesis Constrictive Physiology in Cancer Patients With Pericardial Effusion

• Cho IJ

• KMID: 2524173
• DOI: http://doi.org/10.4070/kcj.2021.0382

Abstract

no abstract available

Reference

1. Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology. 2013; 124:224–232. PMID: 23571453.

2. Imazio M. Pericardiocentesis with extended drainage and colchicine: new indication for malignant pericardial effusions? J Am Coll Cardiol. 2020; 76:1562–1563. PMID: 32972533.

3. Sagristà-Sauleda J, Angel J, Sánchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med. 2004; 350:469–475. PMID: 14749455.

4. Miranda WR, Newman DB, Oh JK. Effusive-constrictive pericarditis: Doppler findings. Curr Cardiol Rep. 2019; 21:144. PMID: 31758271.

5. Kim KH, Miranda WR, Sinak LJ, et al. Effusive-constrictive pericarditis after pericardiocentesis: incidence, associated findings, and natural history. JACC Cardiovasc Imaging. 2018; 11:534–541. PMID: 28917680.

6. Cho IJ, Chang HJ, Chung H, et al. Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion. PLoS One. 2015; 10:e0145461. PMID: 26691279.

7. Kim SR, Kim EK, Cho J, et al. Effect of anti-inflammatory drugs on clinical outcomes in patients with malignant pericardial effusion. J Am Coll Cardiol. 2020; 76:1551–1561. PMID: 32972532.

8. Park H, Yoon HJ, Lee N, et al. Characteristics and clinical outcomes of cancer patients who developed constrictive physiology after pericardiocentesis. Korean Circ J. 2022; 52:74–83. PMID: 34877827.